XML 55 R45.htm IDEA: XBRL DOCUMENT v3.22.1
RELATED PARTIES (Details Narrative) - USD ($)
Jul. 14, 2021
Jan. 26, 2021
Aug. 27, 2018
Mar. 31, 2022
Dec. 31, 2021
Mar. 31, 2021
May 04, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Accounts payable related parties       $ 51,847 $ 155,817    
Accounts receivable net       96,278 79,787    
Net sale   $ 1,000,000          
Accrued Royalties       $ 940,337 $ 706,196    
Beneficially owned       3,534,956      
Cash             $ 500,000
Asset Purchase Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Cash $ 496,100            
Common stock shares issued 14,369            
Consulting Agreement [Member] | Ms Salamone [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Consulting fee $ 177,697            
Cellerate Rx Sub License Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Net sale description     We pay royalties based on our annual Net Sales of CellerateRX (as defined in the sublicense agreement) consisting of 3% of all collected Net Sales each year up to $12,000,000, 4% of all collected Net Sales each year that exceed $12,000,000 up to $20,000,000, and 5% of all collected Net Sales each year that exceed $20,000,000. Minimum royalties of $400,000 per year are payable for the first five years of the sublicense agreement, which was entered on August 27, 2018        
Accrued Royalties       $ 369,233   $ 187,875